Asymmetric Reporting of Harms and Benefits in Randomized Controlled Trials

J Gen Intern Med. 2022 Jun;37(8):2113-2115. doi: 10.1007/s11606-021-07056-1. Epub 2021 Aug 11.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adverse Drug Reaction Reporting Systems*
  • Humans
  • Randomized Controlled Trials as Topic
  • Research Design*